Gout Due to Tacrolimus in a Liver Transplant Recipient.
gout
hyperuricemia
liver transplant
rheumatology
tacrolimus
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
13 Mar 2019
13 Mar 2019
Historique:
entrez:
28
5
2019
pubmed:
28
5
2019
medline:
28
5
2019
Statut:
epublish
Résumé
Patients taking tacrolimus have an increased predisposition to hyperuricemia. Although literature has widely established the risk of gout in patients taking cyclosporine, the widespread use of tacrolimus in patients following liver transplantation necessitates further investigation into the potential connection between the drug's use and gout. Moreover, hyperuricemia in the context of liver transplants is associated with increased morbidities and mortalities. We describe a case of gout in a liver transplant patient taking the calcineurin inhibitor tacrolimus.
Identifiants
pubmed: 31131170
doi: 10.7759/cureus.4247
pmc: PMC6516587
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e4247Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Transplantation. 2001 Nov 27;72(10):1689-91
pubmed: 11726834
Transplant Proc. 2005 Sep;37(7):3119-20
pubmed: 16213325
Transplant Proc. 1990 Feb;22(1):37-40
pubmed: 1689893
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005161
pubmed: 17054241
Arthritis Rheum. 2011 Oct;63(10):3136-41
pubmed: 21800283
World J Hepatol. 2015 Jun 8;7(10):1355-68
pubmed: 26052381
N Engl J Med. 1989 Aug 3;321(5):287-92
pubmed: 2664517
Rheumatology (Oxford). 2017 May 1;56(5):679-688
pubmed: 27498351
BMC Nephrol. 2017 Mar 27;18(1):103
pubmed: 28347282